Literature DB >> 10764719

Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury.

M Date1, K Matsuzaki, M Matsushita, Y Tahashi, F Furukawa, K Inoue.   

Abstract

BACKGROUND: Transforming growth factor beta (TGF-beta) regulates hepatocyte proliferation and biosynthesis of the extracellular matrix. AIMS: This study investigated alternations in sensitivity to TGF-beta1 and binding properties for ligand in hepatocytes and hepatic stellate cells (HSC) after CCl(4) administration.
METHODS: Plasma TGF-beta1 levels in rats after CCl(4) administration were determined using ELISA. Effects of TGF-beta1 were examined by DNA synthesis in hepatocytes and by measurement of fibronectin production in HSC after CCl(4) administration. Binding of (125)I TGF-beta1 was tested in these cells.
RESULTS: Plasma TGF-beta1 levels were increased as early as 24 hours and were maximal by 48 hours. The antiproliferative response to TGF-beta1 decreased in hepatocytes at 48 hours and normalised at 72 hours. Fibronectin production of both normal and injured HSC was affected by TGF-beta1 treatment. Cross linked ligand/receptor complexes were detected in normal hepatocytes and HSC. However, these levels decreased specifically in hepatocytes at 48 hours and normalised by 72 hours.
CONCLUSIONS: Downregulation of TGF-beta receptor occurred in hepatocytes after chemical insult and TGF-beta1 could not transduce its antiproliferative signal. Recovery of TGF-beta receptor expression causes the signal to transduce to the nucleus at 72 hours. In HSC, whenever TGF-beta1 is increased, TGF-beta1 can transduce its signal for fibronectin production via its receptor because signalling receptors are expressed constantly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764719      PMCID: PMC1727924          DOI: 10.1136/gut.46.5.719

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines.

Authors:  G Ramadori; T Knittel; M Odenthal; S Schwögler; K Neubauer; K H Meyer zum Büschenfelde
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

2.  Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

Authors:  H Y Lin; X F Wang; E Ng-Eaton; R A Weinberg; H F Lodish
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

3.  Regulation of TGF beta gene expression in rat liver intoxicated with carbon tetrachloride.

Authors:  J Armendariz-Borunda; J M Seyer; A H Kang; R Raghow
Journal:  FASEB J       Date:  1990-02-01       Impact factor: 5.191

Review 4.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

Review 5.  The cell biology of transforming growth factor beta.

Authors:  J A Barnard; R M Lyons; H L Moses
Journal:  Biochim Biophys Acta       Date:  1990-06-01

6.  Fat-storing cells of the rat liver. Their isolation and purification.

Authors:  D L Knook; A M Seffelaar; A M de Leeuw
Journal:  Exp Cell Res       Date:  1982-06       Impact factor: 3.905

7.  Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.

Authors:  B I Carr; I Hayashi; E L Branum; H L Moses
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

8.  Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

Authors:  W E Russell; R J Coffey; A J Ouellette; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration.

Authors:  P M Lindroos; R Zarnegar; G K Michalopoulos
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

10.  Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture.

Authors:  T Nakamura; Y Tomita; R Hirai; K Yamaoka; K Kaji; A Ichihara
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

View more
  16 in total

1.  The adrenomimetic dobutamine stimulates proliferative activity of hepatocytes and suppresses fibroblasts in mice with posttoxic experimental cirrhosis.

Authors:  A S Gorbenko; N A Setkov
Journal:  Dokl Biol Sci       Date:  2003 Nov-Dec

2.  Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.

Authors:  S Sanz; J B Pucilowska; S Liu; C M Rodríguez-Ortigosa; P K Lund; D A Brenner; C R Fuller; J G Simmons; A Pardo; M-L Martínez-Chantar; J A Fagin; J Prieto
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  YKL-40 expression in CD14⁺ liver cells in acute and chronic injury.

Authors:  Oscar Pizano-Martínez; Irinea Yañez-Sánchez; Pilar Alatorre-Carranza; Alejandra Miranda-Díaz; Pablo C Ortiz-Lazareno; Trinidad García-Iglesias; Adrian Daneri-Navarro; Mónica Vázquez-Del Mercado; Mary Fafutis-Morris; Vidal Delgado-Rizo
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

4.  Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.

Authors:  Katsunori Yoshida; Koichi Matsuzaki; Shigeo Mori; Yoshiya Tahashi; Hideo Yamagata; Fukiko Furukawa; Toshihito Seki; Mikio Nishizawa; Junichi Fujisawa; Kazuichi Okazaki
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

5.  Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.

Authors:  Chau-Hua Chi; I-Li Liu; Wei-Yu Lo; Bor-Song Liaw; Yu-Shan Wang; Kwan-Hwa Chi
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

6.  Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice.

Authors:  Lili Gao; Teruo Utsumi; Keitaro Tashiro; Bo Liu; Dahai Zhang; E Scott Swenson; Yasuko Iwakiri
Journal:  Hepatology       Date:  2013-03-19       Impact factor: 17.425

7.  A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice.

Authors:  Kiyoshi Higashi; Yoshitaka Tomigahara; Hiroaki Shiraki; Kaori Miyata; Toshiyuki Mikami; Toru Kimura; Tadashi Moro; Yutaka Inagaki; Hideo Kaneko
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

Review 8.  TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases.

Authors:  Koichi Matsuzaki; Toshihito Seki; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2013-11-22       Impact factor: 7.527

Review 9.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

Review 10.  Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.

Authors:  Koichi Matsuzaki
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.